Dergiler / Turkish Journal of Gastroenterology / 2020 / Cilt: 31 - Sayı: 8

Magnetic resonance spectroscopy to assess hepatic steatosis in patients with lipodystrophy

Sayfa
588–595
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Further studies are needed to validate the technique and threshold values, which would allow accurate comparison of data acquired by different machines and centers.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: Lipodystrophy is a rare metabolic disorder characterized by a near-total or partial lack of subcutaneous adipose tissue and is associated with insulin resistance.
📊
Temel Bulgular & Veri:Materials and Methods: Between July 2014 and February 2016, 34 patients with lipodystrophy were assessed by MRS for the quantifi cation of hepatic steatosis.
💡
Sonuç & Katkı:Further studies are needed to validate the technique and threshold values, which would allow accurate comparison of data acquired by different machines and centers.
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: Lipodystrophy is a rare metabolic disorder characterized by a near-total or partial lack of subcutaneous adipose tissue and is associated with insulin resistance. We aimed to evaluate the efficacy of magnetic resonance spectroscopy (MRS) imaging to explore the fat content of the liver in patients with lipodystrophy and to determine the relationship between liver fat accumulation and clinical presentations of lipodystrophy. Materials and Methods: Between July 2014 and February 2016, 34 patients with lipodystrophy were assessed by MRS for the quantifi cation of hepatic steatosis. All patients had metabolic abnormalities associated with insulin resistance. Metabolic parameters and the MRS findings were analyzed to identify potential correlations between liver fat content and disease severity. Results: The MRS fat ratios (MRS-FRs) were markedly higher, indicating severe hepatic steatosis in lipodystrophy. Patients with gener alized and partial lipodystrophy had comparable levels of MRS-FRs, although patients with generalized lipodystrophy were significantly younger. Patients with genetic lipodystrophy had elevated MRS-FRs compared with those with acquired lipodystrophy (p=0.042). The MRS-FR was positively correlated with liver enzyme alanine aminotransferase (p=0.028) and serum adiponectin (p=0.043). Conclusion: Our data suggest that MRS might be an effective, non-invasive imaging method to quantify hepatic fat content in patients with lipodystrophy. Further studies are needed to validate the technique and threshold values, which would allow accurate comparison of data acquired by different machines and centers.

🔖

Bu Makaleye Atıf Yap

ALTAY, C., SEÇİL, M., ADIYAMAN, S., SAYDAM, B., DEMİR, T., AKINCI, G., ŞİMŞİR, I. Y., EREN, E., KESKİN, E. T., DEMİR, L., ONAY, H., TOPALOĞLU, H., YÜREKLİ, B. Ş., ÖZDEMİR, N., GEN, R., AKINCI, B. (2020). Magnetic resonance spectroscopy to assess hepatic steatosis in patients with lipodystrophy. Turkish Journal of Gastroenterology, Cilt: 31 - Sayı: 8, 588–595. https://ajindex.com/articles/409226

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Mitchell S. Singular case of absence of adipose matter in the upper half of the body. Am J Med Sci 1885; 90: 2. [Crossref] 2. Berardinelli W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab 1954; 14: 193-204. [Crossref] 3. Dunnigan MG, Cochrane MA, Kelly A, Scott JW. Familial lipoatrophic diabetes with dominant transmission. A new syndrome. QJ Med 1974; 43: 33-48. 4. Kobberling J, Dunnigan MG. Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J Med Genet 1986; 23: 120-7. [Crossref] 5. Akinci B, Meral R, Oral EA. Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities. Curr Diab Rep 2018; 18: 143. [Crossref] 6. Garg A. Clinical review#: Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab 2011; 96: 3313-25. [Crossref] 7. Altay C, Secil M, Demir T, Atik T, Akinci G. Determining residual adipose tissue characteristics with MRI in patients with various subtypes of lipodystrophy. Diagn Interv Radiol 2017: 428-34. [Crossref] 8. Hussain I, Patni N, Ueda M, et al. A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation. J Clin Endocrinol Metab 2018; 103: 1005-14. [Crossref] 9. Mory PB, Crispim F, Kasamatsu T, Gabbay MA, Dib SA, Moises RS. Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation. Arq Bras Endocrinol Metabol 2008; 52: 1252-6. [Crossref] 10. Patni N, Xing C, Agarwal AK, Garg A. Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C. Am J Med Genet A 2017; 173: 2517-21. [Crossref] 11. Montenegro RM, Jr., Costa-Riquetto AD, Fernandes VO, et al. Homozygous and Heterozygous Nuclear Lamin A p.R582C Mutation: Different Lipodystrophic Phenotypes in the Same Kindred. Front Endocrinol (Lausanne) 2018; 9: 458. [Crossref] 12. Simha V, Garg A. Lipodystrophy: lessons in lipid and energy metabolism. Curr Opin Lipidol 2006; 17: 162-9. [Crossref] 13. Akinci B, Onay H, Demir T, et al. Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy. Metabolism 2017; 72: 109-19. [Crossref] 14. Ajluni N, Meral R, Neidert AH, et al. Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort. Clin Endocrinol (Oxf) 2017; 86: 698-707. [Cross